Related Experiment Video
Updated: Jan 16, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
LncRNA PSMA-AS1 affects glioma cell metastasis through mediating pyroptosis via miR-140-3p/SRSF10 axis
Zhengzheng Liu1, Min Wang2, Weilu Kuang1
1Department of Oncology, Xiangya Hospital of Central South University, No.87 Xiangya Road, Kaifu District, Changsha City, 410008 Hunan Province China.
Abstract:
Glioma is a malignant primary tumor of the brain. In recent years, numerous LncRNAs (Long non-coding RNA) have been demonstrated to be potential targets for glioma, and induction of pyroptosis is one of the important directions to inhibit the malignant process of cancer. The role of LncRNA PSMA-AS1, a novel lncRNA, on glioma remain unclear. The aim of this study was to investigate the effects and mechanisms of LncRNA PSMA-AS1 on glioma. PSMA1-AS1 and its potential targets were analyzed using bioinformatics tools and validated using a dual luciferase reporter gene system. Glioma cells were cultured to detect the expression levels of PSMA1-AS1 and its targets. The levels of PSMA1-AS1 and its targets were regulated by transfection and their effects on the viability and metastatic ability of glioma cells as well as on the level of pyroptosis were examined. PSMA1-AS1 expression was elevated in glioma, where miR-140-3p was a downstream target, and was decreased in glioma cells. Inhibition of PSMA1-AS1 promoted pyroptosis and inhibited glioma cell viability and metastatic ability. Overexpression of miR-140-3p had the same effect as inhibition of PSMA1-AS1, whereas inhibition of miR-140-3p reversed the effect of inhibition of PSMA1-AS1 on glioma cells. In addition, SRSF10 is a downstream binding target of miR-140-3p, and inhibition of SRSF10 also promoted pyroptosis and inhibited glioma cells proliferation and metastasis. In conclusion, our results confirmed that PSMA1-AS1 affects glioma cell proliferation and metastasis by regulating pyroptosis through miR-140-3p/SRSF10 axis, suggesting that LncRNA PSMA1-AS1 may be a potential target for glioma.
Insights
Long non-coding RNA PSMA-AS1 promotes glioma progression by inhibiting pyroptosis. Targeting PSMA-AS1 or its downstream miR-140-3p/SRSF10 pathway could be a therapeutic strategy for glioma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioma is a primary malignant brain tumor.
- Long non-coding RNAs (LncRNAs) are implicated in glioma pathogenesis.
- Inducing pyroptosis is a strategy to inhibit cancer progression.
Purpose of the Study:
- To investigate the role and mechanism of LncRNA PSMA-AS1 in glioma.
- To explore the potential of PSMA-AS1 as a therapeutic target for glioma.
Main Methods:
- Bioinformatics analysis and dual luciferase reporter gene assay to identify targets.
- In vitro studies using glioma cell lines to assess proliferation, metastasis, and pyroptosis.
- Transfection techniques to modulate PSMA-AS1 and miR-140-3p expression.
Main Results:
- PSMA-AS1 expression was upregulated in glioma tissues and cell lines.
- PSMA-AS1 targets miR-140-3p, which targets SRSF10.
- Inhibition of PSMA-AS1 or overexpression of miR-140-3p promoted pyroptosis and reduced glioma cell viability and metastasis.
- Inhibition of SRSF10 mimicked these effects.
Conclusions:
- LncRNA PSMA-AS1 promotes glioma cell proliferation and metastasis by suppressing pyroptosis via the miR-140-3p/SRSF10 axis.
- PSMA-AS1 represents a potential therapeutic target for glioma treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
